In this regard, based on immunoprecipitation and western blot analysis using anti-CB and anti-pTyr Abs, respectively, we confirmed not only that CB is tyrosine phosphorylated at a basal level, but also that sorafenib treatment significantly reduces the CB phosphorylation levels.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}